Senior Editor Angie DeRosa sat down Drs. Bekkar, DeNicola, Pandipati and Abel to discuss findings from a recent study on the association with air pollution and heat exposure with adverse obstetrical outcomes, such as preterm birth and stillbirth.
This interview is based on findings from “Association of Air Pollution and Heat Exposure with Preterm Birth, Low Birth Weight, and Stillbirth in the U.S.: A Systematic Review,” recently published in JAMA Network Open.
The review contributes the largest number of recent studies (2007-2019) focusing solely on US populations and is the first, to the authors’ knowledge, to combine the increasingly common exposures of air pollutants and heat associated with a series of adverse obstetrical outcomes – preterm birth, low birth weight, and stillbirth.
It is a first-of-its-kind study focused on the US.
Two of the study’s authors, Drs. Bruce Bekkar and Nate DeNicola, participate in this panel, as well as two maternal-fetal medicine specialists—Drs. Santosh Pandipati and David Abel—who offer the practitioner’s perspective of why this matters and what practicing ob/gyns can do now to address it in their practice.
Dr. Bekkar is a board member of the Climate Action Change Campaign. He has shared original research on the risks to pregnancy in the US at national meetings of the American Public Health Association and the American College of Obstetricians and Gynecologists (ACOG). Dr. DeNicola leads the environmental health efforts within ACOG.
As a maternal-fetal medicine specialist, Dr. Pandipati has issued a call to action on this for healthcare providers; and Dr. Abel also has and has an upcoming article, “Climate Change and Women’s Health: What Practicing OB/GYNs need to know.”
Read ACOG’s position statement on Climate Change and Women’s Health.
Learn more about climate change and its impact on women's health, read this article on climate change and pediatric infectious disease from our sister publication Contemporary Pediatrics.
Buprenorphine use in pregnancy linked to decreased fetal breathing movements
May 18th 2024According to a poster presented at ACOG 2024, use of the synthetic opioid buprenorphine depressed fetal breathing in biophysical profile assessments, but had no significant impact on other factors like amniotic fluid index or fetal tone.
Read More
S4E1: New RNA platform can predict pregnancy complications
February 11th 2022In this episode of Pap Talk, Contemporary OB/GYN® sat down with Maneesh Jain, CEO of Mirvie, and Michal Elovitz, MD, chief medical advisor at Mirvie, a new RNA platform that is able to predict pregnancy complications by revealing the biology of each pregnancy. They discussed recently published data regarding the platform's ability to predict preeclampsia and preterm birth.
Listen
Identifying gaps in syphilis treatment and prenatal care among pregnant individuals
May 17th 2024Preventing congenital syphilis comes down to quick diagnosis and treatment of the infection in pregnancy, and the number of missed opportunities to do so in the United States continues to grow.
Read More
Impact of antiepileptic medications and sex hormones on maternal and child outcomes in epilepsy
May 16th 2024Paula Emanuela Voinescu, MD, PhD, director of the Women's Epilepsy Program at Brigham and Women's Hospital, talked about the influence of sex hormones on maternal outcomes in pregnant women with epilepsy treated with antiseizure medication.
Read More
Prenatal cannabis and nicotine use linked to adverse pregnancy outcomes
May 14th 2024A recent study highlights the heightened risks of maternal and neonatal morbidity and mortality associated with combined cannabis and nicotine use during pregnancy, urging further investigation into their impact on short- and long-term outcomes.
Read More